Hormone-naive prostate cancer

Data from the pivotal phase 3 LATITUDE clinical trial showed Abiraterone acetate ( Zytiga ) plus Prednisone, in combination with...


The androgen receptor inhibitor Enzalutamide ( Xtandi ) is approved for the treatment of metastatic castration-resistant prostate cancer that has...


The androgen receptor inhibitor, Enzalutamide ( Xtandi ) is approved for the treatment of metastatic castration-resistant prostate cancer that has...